跳至主要内容
临床试验/JPRN-UMIN000012092
JPRN-UMIN000012092已完成未知

Further maintenance of remission for a year after infliximab withdrawal in ulcerative colitis treatment: a multicenter, controlled trial in Japan - HAYABUSA study

Center for Clinical Research, Keio University School of Medicine0 个研究点目标入组 250 人开始时间: 2013年12月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients who are maintained remission for longer than 16 weeks. 2) Patients who have relapsed after once induced remission but before registered to the study. 3) Females who are pregnant, breast-feeding, or cannot exclude the possibility of pregnancy. 4) Patients who have a history of severe infusion reaction. 5) Patients who are considered ineligible for this study by the principal investigator or collaborative doctors.

研究者

发起方
Center for Clinical Research, Keio University School of Medicine

相似试验